- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
The seven companies which participated in the Hygiene and Health Zone of Iran Nano 2013 Festival presented their latest achievements in producing nanotechnology-based drugs.
All products in the field of hygiene and health that have been commercialized and presented to the market, have acquired the Nano Scale Certificate and confirmations from Nanotechnology Committee of the Health Ministry.
Exir Nano Sina Company is a knowledge-based company which produces drugs. It has so far produced three drugs by using nanotechnology.
Doxorubicin hydrochloride liposome (an anti-cancer compound) under the commercial name of Sinadoxosome is the name of the drug presented by Exir Nano Sina Company in this year's festival.
The drug is used in the treatment of ovary cancer, breast cancer, multiple myeloma cancer, Kaposi's sarcoma cancer, and in the treatment of patients who suffer from AIDS. It is currently produced in association with Sobhan Pharmaceutical Group. The company has produced Amophleish drug too, which is used in the treatment of leishmaniasis.
Sina Ampholeish drug is waiting to acquire the certificate from the Health Ministry and it is expected that the drug, which is in the form of gel, would be presented to the market within three months.
For more information, please click here
Copyright © Fars News AgencyIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
European Technology Platform for Nanomedicine and ENATRANS European Consortium Launch the 2nd edition of the Nanomedicine Award: The Award to be presented at BIO-Europe conference in Munich, November 2015 July 30th, 2015
Take a trip through the brain July 30th, 2015
Sol-gel capacitor dielectric offers record-high energy storage July 30th, 2015
March 2016; 6th Int'l Conference on Nanostructures in Iran July 29th, 2015
Nanometrics Announces Upcoming Investor Events July 28th, 2015